符文彬教授运用针灸治疗多发性抽动症介绍

目的评价临床路径管理在子宫腺肌症手术治疗中的应用效果。方法将实施临床路径管理的子宫腺肌症手术患者53例设为路径组,未实施临床路径管理的子宫腺肌症手术患者42例作为对照组,对两组患者的住院天数、手术前住院天数、住院费用、药品费用、检查费用、药品费用比例、检查费用比例、术后并发症率和患者满意度等指标进行比较和评价。结果路径组住院天数、手术前住院天数比对照组缩短,差异有统计学意义(P<0.05);路径组药品费用比对照组减少,但住院费用和检查费用较对照组有所增加,差异有统计学意义(P<0.05);路径组的患者满意度有所提高,但术后并发症率无明显改变。结论临床路径应用于妇科子宫腺肌症手术治疗中,规范了医疗行为,有效控制不合理医疗费用,有利于医疗资源的合理使用,促进医疗质量的持续改进。

Research on Clinical Pathway in Surgical Therapy against Adenomyosis

Objective To evaluate the application effect of clinical pathway in the surgical therapy against adenomyosis. Methods 53 cases under clinical pathway management were categorized into the pathway group, and another 42 cases out of clinical pathway management were categorized into the control group. Indices for comparison and evaluation included length of stay, length of stay before surgery, hospitalization expense, medicine expense, examination expense, proportion of medicine expense, proportion of examination expense, rate of postoperative complications, and patient satisfaction etc. Results The length of stay and the length of stay before surgery in the pathway group were shorter than that in the control group, and the difference between them had statistical significance （P〈0.01）. Compared with the control group, the medicine expense reduced but the total hospitalization expense and the examination expense increased in the pathway group, and the difference between them had statistical significance （P〈0.01 or P〈0. 05）. Compared with the control group, the patient satisfaction increased （P〈0.01）. And there was no statistical changes in the rate postoperative complications between the two groups （P~0.05）. Conclusion Clinical pathway could regulate the surgical therapy process against adenomyosis and control effectively irrational medical expense, and it could also facilitate the reasonable usage of medical resources and sustainable improvement of medical quality.